UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000044470 |
|---|---|
| Receipt number | R000050800 |
| Scientific Title | A phase Ib study of Durvalumab in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer. An additional study for immunological prognostic factors |
| Date of disclosure of the study information | 2021/06/08 |
| Last modified on | 2022/12/08 12:30:11 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/06/08 14:27:46 | ||
| 2 | Update | 2021/12/08 08:52:27 | Recruitment status |
|
| 3 | Update | 2022/12/08 12:30:11 | Recruitment status |
